MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and ...
In a significant achievement in advanced cancer care and surgical excellence, AIIMS Patna has successfully preserved the leg of a 25-year-old patient diagnosed with a rare and aggressive bone cancer, ...
New device expands AtriCure’s market opportunity in post-operative pain management while addressing a significant unmet clinical need Recently cleared under an FDA 510(k), the cryoXT device is ...